title: Lichen Planus in Irradiated Skin During Nivolumab Treatment.
authors.affiliation: Department of Dermatology, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
authors.forename: Takaya
authors.initials: T
authors.lastname: Komori
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Honda
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Irie
authors.forename: Atsushi
authors.initials: A
authors.lastname: Otsuka
authors.forename: Kenji
authors.initials: K
authors.lastname: Kabashima
mesh_terms: D000279:Administration, Cutaneous; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001706:Biopsy; D001943:Breast Neoplasms / Q000473:pathology*; D005260:Female; D005477:Fluprednisolone / Q000008:administration & dosage / Q000031:analogs & derivatives; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D008010:Lichen Planus / Q000139:chemically induced* / Q000473:pathology; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008198:Lymph Nodes / Q000473:pathology / Q000528:radiation effects*; D008207:Lymphatic Metastasis; D000077594:Nivolumab; D011855:Radiodermatitis / Q000139:chemically induced* / Q000473:pathology; D011878:Radiotherapy / Q000009:adverse effects; D012074:Remission Induction; D012307:Risk Factors; D012867:Skin / Q000187:drug effects* / Q000473:pathology / Q000528:radiation effects*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D005938:Glucocorticoids; D000077594:Nivolumab; D005477:Fluprednisolone; C015808:difluprednate